Results 61 to 70 of about 4,410 (137)
Endoscopic Orbital Decompression for Graves’ Orbitopathy – A Vietnam Study
Thi My Hanh Pham,1,2 Chien Thang Nguyen,1 Quoc Tung Mai,2 Thi Huong Giang Bui,2 Dung Hoa Do,2 Peter McCluskey,3 Trong Van Pham2 1Department of Ophthalmology, 103 Military Hospital, Hanoi, Vietnam; 2Department of Ophthalmology, Hanoi Medical University ...
Pham TMH +6 more
doaj
Background Graves’ orbitopathy (GO) is an autoimmune condition, which is associated with poor clinical outcomes including impaired quality of life and socio-economic status.
P. Perros +23 more
doaj +1 more source
Orbital decompression in Graves` orbitopathy
Introduction. This paper was aimed at presenting our experience and results in the surgical management for proptosis in patients with Graves` orbitopathy. Material and Methods. This is a retrospective, interventional, non-comparative case series review.
Miroslav, Knezević +5 more
openaire +3 more sources
Purpose. To study the clinical significance of the Graves’ orbitopathy-specific quality of life (GO-QOL) questionnaire in mainland Chinese patients. Methods.
Peng Zeng +6 more
doaj +1 more source
Case series of dermopathy in autoimmune thyroid disease [PDF]
Graves' disease (GD) is an autoimmune disease that can affect other tissues in addition to the thyroid gland. The clinical manifestations are a result of the impact of TSH receptor antibodies.
Janić Tamara +8 more
doaj +1 more source
The clinical tomographic interconnection in diplopia of patients with Graves' orbitopathy
There was investigated the relationship between the clinical features of the diplopia in patients with the Graves’ orbitopathy and the specific signs of the orbit obtained by the multi-slice CT scanning in the study.
doaj +1 more source
Prevention of Graves' Orbitopathy: Early Diagnosis of Thyroid-Associated Orbitopathy in Graves' Disease [PDF]
In spite of 200 years of research, the pathogenesis of Graves' orbitopathy (GO) remains an enigma.
openaire +3 more sources
Objective Thyrotoxicosis is established risk factor for osteoporosis due to increased bone turnover. Glucocorticoids often administered for Graves' orbitopathy (GO) have additional negative effect on bone mineral density (BMD). Our aim was to examine the
Mira Siderova +2 more
doaj +1 more source
Key Clinical Message A few cases of thyroid eye disease following alemtuzumab therapy have been described in patients with multiple sclerosis. Our patient is the first case of Graves’ orbitopathy after alemtuzumab conditioning for hematopoietic stem cell
Luminita Nicoleta Cima +5 more
doaj +1 more source
Targeted immunotherapies for Graves’ thyroidal & orbital diseases
BackgroundGraves’ hyperthyroidism and its associated Graves’ orbitopathy are common autoimmune disorders associated with significant adverse health impact.
Alan Chun Hong Lee, George J. Kahaly
doaj +1 more source

